In the past week, NLSP stock has gone up by 14.47%, with a monthly gain of 23.33% and a quarterly plunge of -2.63%. The volatility ratio for the week is 7.56%, and the volatility levels for the last 30 days are 4.24% for NLS Pharmaceutics Ltd The simple moving average for the past 20 days is 11.84% for NLSP’s stock, with a -41.53% simple moving average for the past 200 days.
Is It Worth Investing in NLS Pharmaceutics Ltd (NASDAQ: NLSP) Right Now?
Company’s 36-month beta value is -0.08.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for NLSP is 2.28M, and currently, short sellers hold a 4.01% ratio of that floaft. The average trading volume of NLSP on May 25, 2025 was 147.60K shares.
NLSP) stock’s latest price update
The stock of NLS Pharmaceutics Ltd (NASDAQ: NLSP) has decreased by -5.13 when compared to last closing price of 1.95. Despite this, the company has experienced a 14.47% gain in its stock price over the last five trading sessions. prnewswire.com reported 2025-05-21 that ZURICH, May 21, 2025 /PRNewswire/ — NLS Pharmaceutics Ltd. (NASDAQ: NLSP), a Swiss clinical-stage biopharmaceutical company focused on central nervous system (“CNS”) disorders, announces that it will present new preclinical data on Mazindol ER at the 2025 Annual Meeting of the American Society of Clinical Psychopharmacology (“ASCP”).
NLSP Trading at 19.68% from the 50-Day Moving Average
After a stumble in the market that brought NLSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.94% of loss for the given period.
Volatility was left at 4.24%, however, over the last 30 days, the volatility rate increased by 7.56%, as shares surge +23.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +20.92% upper at present.
During the last 5 trading sessions, NLSP rose by +14.47%, which changed the moving average for the period of 200-days by -77.28% in comparison to the 20-day moving average, which settled at $1.6542. In addition, NLS Pharmaceutics Ltd saw -12.32% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NLSP
The total capital return value is set at 0.32.
Based on NLS Pharmaceutics Ltd (NLSP), the company’s capital structure generated -0.23 points at debt to capital in total, while cash flow to debt ratio is standing at -0.89. The debt to equity ratio resting at -0.18. The interest coverage ratio of the stock is -14.19.
Currently, EBITDA for the company is -11.8 million with net debt to EBITDA at -0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.69.
Conclusion
In a nutshell, NLS Pharmaceutics Ltd (NLSP) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
